Objectives

After participating in this educational activity, attendees should be able to:
1. Describe the utility of TEG/Rotem in management of acutely bleeding patients.
2. Compare TEG/Rotem witih standard coagulation assays.
3. Discuss how to use TEG/Rotem at BMC.
4. Explain the existing evidence supporting the use of TEG/Rotem to reduce mortality, blood product transfusions, and the need for additional hemostatic interventions in different adult patient populations.
5. Review the incidence and causes of postoperative sore throat in elective surgical patients.
6. Discuss pharmacological and nonpharmacological variables that may reduce the incidence of postoperative sore throat.

Faculty

Michael Chalifoux, MD
Assistant Professor of Medicine
University of Massachusetts Medical School-Baystate
Physician
Baystate Medical Center 

Steven Singley, CRNA
Certified Registered Nurse Anesthetist
University of Massachusetts Medical School-Baystate
Physician
Baystate Medical Center

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.